Gain Therapeutics Inc (GANX) earnings · $53.0M cap
These earnings events as JSON? API free 100/dayGain Therapeutics Inc (GANX) is a biotechnology company listed on US.
This GANX earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported GANX revenue for 2023-09-30 was $55.2K. Net income was -$4.7M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. GANX currently screens at market cap $53.0M.
When the next GANX 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 0.0% from 2023-06-30 to 2023-09-30. An earnings headline that ignores that move is noise.
Not investment advice. Full GANX research stays on the stock page; the tape stays on the quote page.
GANX earnings FAQ
What are GANX's latest revenue and net income?
Latest cached Gain Therapeutics Inc (GANX) revenue for Sep 30, 2023 was $55.2K. Net income was -$4.7M. Statements: https://lician.com/financials/ganx
What is GANX's latest diluted EPS?
Latest cached Gain Therapeutics Inc (GANX) diluted EPS for Sep 30, 2023 was -$0.37.
What period does the latest GANX earnings print cover?
The latest cached Gain Therapeutics Inc (GANX) earnings print covers Sep 30, 2023. The prior cached period on this page is Jun 30, 2023.
How did GANX revenue change from the prior cached period?
Cached Gain Therapeutics Inc (GANX) revenue was unchanged from $55.2K (Jun 30, 2023) to $55.2K (Sep 30, 2023). Statements: https://lician.com/financials/ganx
Where are GANX earnings listed?
Cached earnings facts for Gain Therapeutics Inc (GANX) are listed at https://lician.com/earnings/ganx. Statements: https://lician.com/financials/ganx
Not investment advice.